Article

Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.

Diabetes Research Institute, University of Düsseldorf, Germany.
Diabetologia (Impact Factor: 6.88). 08/1998; 41(8):891-7. DOI: 10.1007/s001250051004
Source: PubMed

ABSTRACT Type I diabetes mellitus may represent a heterogeneous disorder with a distinct pathogenesis in patients with young and adult onset of the disease. To investigate whether serological markers directed to different autoantigens have the potential to distinguish acute onset from slowly progressive Type I diabetes we analysed antibodies to tyrosine phosphatases IA-2/ICA512 (IA-2A) and IA-2beta/phogrin (IA2betaA), antibodies to GAD65 (GADA) and cytoplasmic islet cell antibodies (ICA) in a non-selected group of diabetic patients clinically classified as having Type I or Type II diabetes at diagnosis. Both IA-2A and IA-2betaBA were found to be positively associated with onset before the age of 20 years and the presentation of classical features of Type I diabetes. In Type I diabetes 56 % (112/200) of patients were positive for IA-2A and 38 % (76/200) for IA-2betaA. In contrast, only 1 of 785 (0.1 %) patients with Type II diabetes had IA-2A and all of them were negative for IA-2betaA (p < 0.001). Among the patients with Type II diabetes 7.6% (n = 60) were ICA positive and 2.8% (n = 22) had GADA suggesting the presence of slowly progressive Type I diabetes. GADA were found in 8 of 60 (13.3 %) ICA positive subjects which was lower than the percentage detected in patients with acute onset of diabetes (115/157 73.2%) (p < 0.001). Blocking of double antibody positive sera showed that only 3 of 8 (37.5 %) patients with slowly progressive diabetes had ICA restricted to GAD or IA-2 whereas ICA were completely inhibited in 12 of 20 (60.0 %) patients with Type I diabetes. Among 193 patients with Type II diabetes available for follow-up, 35 % of ICA positives, 58 % of GADA positives and 60 % of those positive for both markers required insulin by 3 years. However, using strict criteria for the switch to insulin treatment the corresponding sensitivity of each marker was only low (9%, 10% and 5%). We show that clinical subtypes of Type I diabetes are associated with distinct humoral autoimmunity. IA-2A and GADA were associated with classical features of Type I diabetes whereas GADA and an uncharacterized ICA subspecificity indicate slowly progressive disease.

0 Followers
 · 
58 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Diabetes mellitus is mainly subdivided into type 1 diabetes (DM1) or type 2 (DM2). The existence of genetic, metabolic and immunological mechanisms involving these two entities, and clinical evidence of an autoimmune form of diabetes diagnosed in adults (LADA), suggests the possibility of a pathophysiological continuity. Objective To describe the main genetic, immunological and metabolic mechanisms common to the development of DM1 and DM2. To support the hypothesis of a pathophysiological continuum between the two main subtypes of diabetes. Methods Systematic search in PubMed database of the original articles or systematic reviews published until April 2013. The search terms used were: «type 1 diabetes mellitus», «type 2 diabetes mellitus», «latent auto-immune diabetes in adults», «pathophysiology». Conclusions LADA assumes, under the pathophysiological point of view, an intermediate position between DM1 and DM2, sharing genetic and immunological mechanisms. It was found that self-reactivity and apoptosis of the β cell are not exclusive processes of DM1, and that insulin resistance, being a key factor in the pathogenesis of DM2, determines a more rapid progression of DM1. Phenotypic expression of diabetes results from the imbalance created between these pathophysiological mechanisms, along the course of the disease. More than the classification of the patient in a subtype of diabetes it is the recognition of mechanisms leading to metabolic changes that allows an adequate therapy. The definition of LADA as an isolated entity could be withdrawn.
    01/2013; 8(1):44–49. DOI:10.1016/j.rpedm.2013.05.002
  • [Show abstract] [Hide abstract]
    ABSTRACT: Anti-parietal cell (APC) antibodies and pernicious anemia (PA) were evaluated in patients with type 1 diabetes (n=75) and in controls. A higher frequency of APC (13.3%) and PA (4%) was found in cases than in controls (p=0.003), associated with other autoimmune diseases (p=0.003), but not with insulin or PTPN22 polymorphisms.
    Diabetes research and clinical practice 08/2013; DOI:10.1016/j.diabres.2013.08.008 · 2.54 Impact Factor
  • Source

Preview

Download
0 Downloads
Available from